» Articles » PMID: 38928589

A Narrative Review of the Dorsal Root Ganglia and Spinal Cord Mechanisms of Action of Neuromodulation Therapies in Neuropathic Pain

Overview
Journal Brain Sci
Publisher MDPI
Date 2024 Jun 27
PMID 38928589
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropathic pain arises from injuries to the nervous system in diseases such as diabetes, infections, toxicity, and traumas. The underlying mechanism of neuropathic pain involves peripheral and central pathological modifications. Peripheral mechanisms entail nerve damage, leading to neuronal hypersensitivity and ectopic action potentials. Central sensitization involves a neuropathological process with increased responsiveness of the nociceptive neurons in the central nervous system (CNS) to their normal or subthreshold input due to persistent stimuli, leading to sustained electrical discharge, synaptic plasticity, and aberrant processing in the CNS. Current treatments, both pharmacological and non-pharmacological, aim to alleviate symptoms but often face challenges due to the complexity of neuropathic pain. Neuromodulation is emerging as an important therapeutic approach for the treatment of neuropathic pain in patients unresponsive to common therapies, by promoting the normalization of neuronal and/or glial activity and by targeting cerebral cortical regions, spinal cord, dorsal root ganglia, and nerve endings. Having a better understanding of the efficacy, adverse events and applicability of neuromodulation through pre-clinical studies is of great importance. Unveiling the mechanisms and characteristics of neuromodulation to manage neuropathic pain is essential to understand how to use it. In the present article, we review the current understanding supporting dorsal root ganglia and spinal cord neuromodulation as a therapeutic approach for neuropathic pain.

Citing Articles

A perspective: neuraxial therapeutics in pain management: now and future.

DeAndres J, Dickenson A, Hayek S, Linninger A, Yaksh T Front Pain Res (Lausanne). 2024; 5:1505019.

PMID: 39720319 PMC: 11666549. DOI: 10.3389/fpain.2024.1505019.

References
1.
Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

2.
Moulin D, Boulanger A, Clark A, Clarke H, Dao T, Finley G . Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014; 19(6):328-35. PMC: 4273712. DOI: 10.1155/2014/754693. View

3.
Fernandez-de-Las-Penas C, Nijs J, Cagnie B, Gerwin R, Plaza-Manzano G, Valera-Calero J . Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain. Life (Basel). 2023; 13(3). PMC: 10059732. DOI: 10.3390/life13030694. View

4.
Baron R, Binder A, Wasner G . Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010; 9(8):807-19. DOI: 10.1016/S1474-4422(10)70143-5. View

5.
Joosten E, Franken G . Spinal cord stimulation in chronic neuropathic pain: mechanisms of action, new locations, new paradigms. Pain. 2020; 161 Suppl 1:S104-S113. PMC: 7434213. DOI: 10.1097/j.pain.0000000000001854. View